logo

For the Inventor, By the Inventor

St. Charles, MO, United States of America

Dudley E McMackins

USPTO Granted Patents = 16

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 114(Granted Patents)


Company Filing History:

goldMedal15 out of 3,288 
 
Monsanto Company
 patents
silverMedal1 out of 1,323 
 
G.d. Searle & Company
 patents

Years Active: 1978-1997

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5624956 - Urea derivatives useful as platelet aggregation inhibitors (1997-04-29),
2. 5475025 - Urea derivatives useful as platelet aggregation inhibitors (1995-12-12),
3. 5314902 - Urea derivatives useful as platelet aggregation inhibitors (1994-05-24),
4. 5220050 - Peptide mimetic compounds useful as platelet aggregation inhibitors (1993-06-15),
5. 4736063 - Sorbic acid process (1988-04-05),
6. 4672140 - Acyloxyalkenoic acids and process therefor (1987-06-09),
7. 4564689 - Product separation from electrolyte salts maintained in molten state (1986-01-14),
8. 4560775 - Production of lactone in molten salt electrolysis (1985-12-24),
9. 4526990 - Synthesis of .gamma.-vinyl-.gamma.-butyrolactone from acetoxyhexenoic (1985-07-02),
10. 4380650 - Lactone process (1983-04-19),
11. 4356317 - Acyloxyalkenoic acids and process therefor (1982-10-26),
12. 4204997 - Asymmetric amination of 1,3-dienes (1980-05-27),
13. 4130590 - Production of unsaturated amines (1978-12-19),
14. 4120901 - Production of primary and secondary amines by reaction of ammonia with (1978-10-17),
15. 4100196 - Production of N-(alkadienyl)amines (1978-07-11),

Title: The Innovative Contributions of Dudley E McMackins

Introduction

Dudley E McMackins is a notable inventor based in St. Charles, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit platelet aggregation. With a total of 16 patents to his name, McMackins has established himself as a key figure in innovation.

Latest Patents

Among his latest patents are two notable inventions related to urea derivatives. The first patent focuses on novel urea derivatives and pharmaceutical compositions that serve as platelet aggregation inhibitors. The second patent also centers on urea compounds that inhibit platelet aggregation, along with the pharmaceutical compositions and methods for utilizing these compounds. These innovations highlight his commitment to advancing medical science.

Career Highlights

Throughout his career, Dudley E McMackins has worked with prominent companies such as Monsanto Company and G.D. Searle & Company. His experience in these organizations has undoubtedly contributed to his expertise and success as an inventor.

Collaborations

Some of his notable coworkers include James P Coleman and Richard C Hallcher. Their collaboration has likely played a role in the development of his innovative ideas and patents.

Conclusion

Dudley E McMackins is a distinguished inventor whose work in developing urea derivatives has made a significant impact in the pharmaceutical industry. His numerous patents and collaborations reflect his dedication to innovation and advancement in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…